Mucokinetica

Biopharmaceutical company focused on discovering and developing medicines for respiratory diseases where accumulated mucus contributes to pathology. Core focus is on mechanisms that control mucociliary propulsion and on partnering for inhalation drug delivery to improve mucus clearance and reduce infection, inflammation and lung-function decline.